Intersect ENT, Inc. Embedded Derivative, Gain (Loss) on Embedded Derivative, Net
Intersect ENT, Inc. reported Embedded Derivative, Gain (Loss) on Embedded Derivative, Net of -$13.00 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-02.
Discontinued › Income Statement › Other Income
us-gaap:EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet · last filed 2021-11-02
- Intersect ENT, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2021-09-30 was -$13.00M, a 1400.00% decline year-over-year.
- Intersect ENT, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2021-06-30 was $700.00K.
- Intersect ENT, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2020-09-30 was $1.00M.
- Intersect ENT, Inc. embedded derivative, gain (loss) on embedded derivative, net for the quarter ending 2020-06-30 was -$1.80M.
| Period end | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 3 month | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 6 month | Embedded Derivative, Gain (Loss) on Embedded Derivative, Net 9 month |
|---|---|---|---|
| 2021-09-30 | -$13.00M 10-Q · filed 2021-11-02 | -$12.30M derived: sum of 2 quarters · filed 2021-11-02 | -$12.70M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $700.00K 10-Q · filed 2021-08-06 | $300.00K 10-Q · filed 2021-08-06 | |
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-02 | -$800.00K derived: sum of 2 quarters · filed 2021-11-02 | -$800.00K 10-Q · filed 2021-11-02 |
| 2020-06-30 | -$1.80M 10-Q · filed 2021-08-06 | -$1.80M 10-Q · filed 2021-08-06 |